Divine Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Haryana, Haryana, India, established in 2000.
2000 Haryana, Haryana, India Struck Off
Last Updated:
Access Report
About Divine Drugs Private Limited

Divine Drugs Private Limited, a struck off private limited company, was established on 27 June 2000 in Haryana, Haryana, India. Engaging in medicinal chemical & botanical products within the chemicals sector, it holds CIN: U24239HR2000PTC034507. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.33 M.

Its leadership includes Vinay Kumar Gupta (Director), Poonam Gupta (Director). Past directors included Pranesh Kumar Tayal, Tripti Tayal. Its latest AGM occurred on 30 September 2015, with the balance sheet filed on 31 March 2015. It is based at 4395 Dal Mandiambala Cantt, Haryana, Haryana, 133001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239HR2000PTC034507

  • Registration Number

    034507

  • Incorporation Date

    27 June 2000

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.33 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.33 M
  • Company Age 25 Year, 7 Months
  • Last Filing with ROC 31 Mar 2015
Company report

Divine Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Divine Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Divine Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Vinay Kumar Gupta Director 11 Jul 2012 Current
Poonam Gupta Director 06 Mar 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 07 Mar 2014 Past
Pramod Abcsdd Director 12 Jul 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Divine Drugs.

Enhance accessibility to Divine Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Divine Drugs revenue growth over time
Divine Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Divine Drugs?

Unlock access to Divine Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Divine Drugs?

Unlock and access historical data on people associated with Divine Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Divine Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Divine Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Divine Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Divine Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records. was completed.

  • Balance Sheet

    Divine Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Progress on Poonam Gupta was appointed as a Director was appointed as a Director on 06 Mar 2014 & has been associated with this company since 11 years 11 months . was documented.

  • Director Appointment

    The activity Vinay Kumar Gupta was appointed as a Director was appointed as a Director on 11 Jul 2012 & has been associated with this company since 13 years 7 months . was completed.

  • Company Incorporation

    The activity Divine Drugs Private Limited was registered on 27 Jun 2000 with Roc Delhi & aged 25 years 7 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Divine Drugs Private Limited?

The CIN of Divine Drugs Private Limited is U24239HR2000PTC034507.

Where is Divine Drugs Private Limited headquartered?

Divine Drugs Private Limited is headquartered at 4395 Dal Mandiambala Cantt, Haryana, Haryana, 133001.

When was Divine Drugs Private Limited incorporated?

Divine Drugs Private Limited was incorporated on 27 June 2000.

Who are the current directors of Divine Drugs Private Limited?

The current directors of Divine Drugs Private Limited are

What is the primary industry of Divine Drugs Private Limited?

The primary industry of Divine Drugs Private Limited is Chemicals.

Is Divine Drugs Private Limited a listed company?

Divine Drugs Private Limited is unlisted.

What is the capital structure of Divine Drugs Private Limited?

The authorized capital of Divine Drugs Private Limited is ₹0.50 M, and the paid-up capital is ₹0.33 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available